First Manhattan Co

SEC CIK: 0000728083
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CERE holding history

Cerevel Therapeutics Holdings, Inc. in every 13F filed by First Manhattan Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CERE overview All 13F holders of CERE Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2023

Holdings of CERE by First Manhattan Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−100−100.0%	Sold out	Holders
Q1 2024	100	$4.23K	<0.1%	00.0%	Unchanged	Holders
Q4 2023	100	$4.24K	<0.1%	00.0%	Unchanged	Holders
Q3 2023	100	$2.18K	<0.1%	+100	New	Holders